Square has expanded its invite-only pilot for CBD products in the U.S. to all of its existing merchant accounts, but is charging a premium.
Processing Content
The pilot program Square launched in May 2019 was called an “invite only beta test” for some CBD products at select merchants. One of Square's challenges is to determine how to keep other marijuana products that are still considered illegal under federal law from being processed on its terminals.
On it Townsquare blogpost the Square states that for CBD to be processed that it must be hemp-derived and contain less than 0.3% THC. However, processing transactions is not going to be cheap despite any merchant testimonials that state otherwise.
Square, a credit card reader made for smartphones, is demonstrated for a photograph in New York, U.S., on Monday, Oct. 25, 2010. Square Inc.'s mobile-payment technology allows smartphone users to make credit card payments and the availability of funding for new ventures. Photographer: Jin Lee/Bloomberg
Jin Lee/Bloomberg
CBD laws have been loosening quickly. CBD and hemp, which are both cannabis products, were legalized federally when President Trump signed the U.S. Farm Bill in December 2018 as long as they contain less than 0.3% THC, the psychoactive chemical in cannabis that creates a high.
There has been a boom in CBD sales with celebrities and sports athletes, such as former New England Patriots star Rob Gronkowski, promoting their use. In May the NFL announced it will conduct research on joint pain management using treatments that will include cannabis, cannabinoids and CBD.
Square highlighted one merchant testimonial in its blog post from Bluebird Botanicals’ chief operating officer, Kevin Liebrock, as stating: “With Square, we don’t just get better rates—we’re also treated with respect and trust. And now, instead of waiting for checks in the mail, we get paid the next business day.”
Square is taking advantage of merchants who have largely been deprived of traditional banking and payments processing due to the federal ban on cannabis where alternative processors such as Nature Pay charge 5.95% + $0.30 per transaction.
Square’s prices are lower than alternative processor yet higher than other products such as e-cigarettes and alcohol. However, Square does prohibit internet/mail order/telephone order of age-restricted products (e.g., tobacco) according to its terms of service.
Square’s pricing is for CBD is 3.90% + $0.10 for in-person transactions, 4.20% for online and in-app purchases and 4.80% + $0.15 for keyed, card on file and virtual transactions. In comparison Square charges 2.60% + $01.0 for other products sold in person, 2.90% +$0.30 for e-commerce transactions and 3.50% + $0.15 for keyed, card on file and virtual transactions on non-CBD products.
Part of the growing "phishing-as-a-service" economy, the Spiderman kit offers novice hackers sophisticated tools to target customers of major EU institutions.
Banks may need to offer people over the age of 65 more than just digital experiences, according to an executive at J.D. Power, which surveyed more than 11,000 retail banking customers.
In a move some industry observers call "dangerous and irresponsible," the administration is taking down consumer protection guardrails that have been put up by states like California and Colorado.
Rohit Chopra is named senior advisor to the Democratic Attorneys General Association's working group on consumer protection and affordability; Flagstar Bank adds additional wealth-planning capabilities to its private banking division; Chime promotes three members of its executive leadership team; and more in this week's banking news roundup.
The Office of the Comptroller of the Currency Friday approved national trust charter applications for five crypto firms, affirming the administration's push to allow crypto companies the ability to take deposits.
Kansas City Federal Reserve President Jeffrey Schmid and Chicago Fed President Austan Goolsbee said in statements Friday that their dissents from this week's interest rate decision were spurred by inflation concerns and a lack of sufficient economic data.
